EUQ13NCT07119606
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Eligibility criteria expanded, about 4 words
- Study description revised
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Better Understanding the Clinical Variability of the Phelan-McDermid Syndrome
Timeframe: 18 months
Arms and interventions
SHANK3 MutationExperimental
Diagnostic tests: SHANK3 mutation
Sites
1 site in 1 country
- Robert Debré HospitalParis, Ap-hp / DRCI, France